I am an Academic Clinical Microbiologist. In my daily practice, I see patients with infections that are becoming increasingly difficult to treat. My research focuses on developing new ways to tackle antimicrobial resistance (AMR): developing and using new methods to track the spread of resistance, utilising rapid diagnostic tools, optimising the care of patients with multi-drug resistant organisms, and translating the research findings back to patient care.
et al., 2022, The clinical presentation of monkeypox: a retrospective case-control study of patients with possible or probable monkeypox in a West London cohort, International Journal of Infectious Diseases, ISSN:1201-9712
et al., 2022, A practical laboratory method to determine ceftazidime-avibactam-aztreonam synergy in patients with New Delhi Metallo-beta-lactamase (NDM) producing Enterobacterales infection, Journal of Global Antimicrobial Resistance, Vol:29, ISSN:2213-7165, Pages:558-562
et al., 2022, How to adapt an intestinal microbiota transplantation program to reduce the risk of invasive multidrug-resistant infection, Clinical Microbiology and Infection, Vol:28, ISSN:1198-743X, Pages:502-512
et al., 2022, The potential utility of fecal (or intestinal) microbiota transplantation in controlling infectious diseases, Gut Microbes, Vol:14, ISSN:1949-0976, Pages:1-22
et al., 2022, RELATIVE CHANGE OF ENTEROCOCCUS FAECIUM, SELECTED COMMENSAL BACTERIA AND CYTOKINES ARE SEEN IN PATIENTS COLONIZED WITH MULTIDRUG-RESISTANT ORGANISMS WHO UNDERGO INTESTINAL MICROBIOTA TRANSPLANTATION, W B SAUNDERS CO-ELSEVIER INC, Pages:S218-S219, ISSN:0016-5085